The 3rd Tubeless and ERAS Academic Symposium was held in Hengqin
Recently, the first China Respiratory Health Conference was held in Hengqin, Guangdong, under the theme “Protecting Health, Creating the Future.” This event was co-hosted by several prominent institutions, including the Guangzhou National Laboratory, the National Respiratory Medicine Center, and the Guangdong Province Chest Disease Society, among others.
During the conference, the Tubeless and ERAS academic seminar featured renowned experts who engaged in discussions on the applications of Tubeless and ERAS across various disciplines, exploring their current status and future potential.
Professor Liu Jun, the chair of the forum from the First Affiliated Hospital of Guangzhou Medical University, expressed in his opening remarks that the industry has embraced the concept of Tubeless rapid recovery. He noted that there is a collective understanding not only about the depth of research required but also about the broader implications. He hopes that interdisciplinary discussions will foster a more integrated approach based on autonomous respiratory anesthesia technology, leading to the development of more Chinese solutions and wisdom to benefit patients.
Professor He Jianxing, also from the First Affiliated Hospital of Guangzhou Medical University, emphasized that every technological innovation aims to enhance patient care. He highlighted that simply having smaller surgical incisions is not enough; patients deserve to recover with dignity and improved outcomes. The introduction of Tubeless ERAS signifies a significant advancement that also benefits other fields like orthopedics, urology, and cardiology.
The ceremony for the release of the “Expert Consensus on the Clinical Standardization of Robot-Assisted Percutaneous Lung Biopsy Techniques” was later chaired by Professor Cui Fei. He introduced the consensus, noting the rising incidence of lung cancer and the ongoing efforts to detect lung nodules and early-stage cancers sooner to reduce mortality rates. He discussed the crucial role of biopsy and precise preoperative imaging in diagnosing lung conditions, stressing that reliance on rudimentary measuring tools and individual experience can lead to risks and reduced accuracy. Amidst these challenges, several robotic and artificial intelligence tools have begun clinical use, though a standardized operating protocol remains to be established. Under the guidance of academician Zhong Nanshan and with the leadership of Professor He, a multidisciplinary team from the First Affiliated Hospital drafted this consensus, which covers various procedural guidelines and assessments for robot-assisted biopsies.
The academic presentations were divided into three segments, focusing on the applications of Tubeless and ERAS technology in thoracic surgery, multidisciplinary approaches, and practices in grassroots hospitals. Esteemed experts, including Professor Chen Keneng from Peking University Cancer Hospital and Professor Li Hui from Capital Medical University’s Beijing Chaoyang Hospital, shared their clinical experiences with autonomous respiratory anesthesia technology. They discussed the indications, contraindications, complications management of Tubeless technology, and established multi-parameter predictive models while providing numerous clinical case studies. The conference particularly highlighted Tubeless technology applications in ENT surgeries, treatment of congenital heart diseases, pediatric thoracic surgeries, urological procedures, and elderly hip fractures, exploring its combination with other minimally invasive approaches like single-port robotic surgery.
In his concluding remarks, Professor He reaffirmed the achievements of Tubeless and ERAS technologies while looking ahead toward their future developments. He believes these innovations can revolutionize thoracic surgery and advance the fields of surgery, anesthesiology, emergency medicine, and critical care. He encourages more professionals to engage actively in promoting and advancing Tubeless and ERAS technologies, ultimately benefiting patients significantly.
